Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Multiplex PCR Platform Detects 21 Common Respiratory Organisms

By LabMedica International staff writers
Posted on 01 Feb 2010
A user-friendly multiplex polymerase chain reaction (PCR) platform is capable of detecting 21 common respiratory viruses and bacteria.

The FilmArray is simplified molecular testing; easy-to-use, the massive multiplex PCR turns a sample into results in less than 1 hour. More...
It requires only 5 minutes of hands-on time.

A product of Idaho Technology (ITI; Salt Lake City, UT, USA), the FilmArray integrates sample preparation, amplification, detection, and analysis into one system that is fully automated and is capable of rapidly detecting more than 100 targets in one sample.

Clinical trials of the FilmArray RP will be conducted at the Children's Medical Center (Dallas, TX, USA) in association with University of Texas (UT) Southwestern Medical Center, (Dallas, TX, USA); the Detroit Medical Center, (Detroit, MI, USA); and the Medical University of South Carolina (Charleston, SC, USA).

Nasopharyngeal swab specimens from 1,000 patients will be tested using the FilmArray RP and compared to results from conventional as well as other molecular diagnostic technologies. If that the trials are successful, the company will submit a 510k application to the US Food and Drug Administration (FDA; Silver Spring, MD, USA) for use of the FilmArray RP as an in vitro diagnostic (IVD) product for patients with symptoms of upper respiratory tract infection.

Kirk Ririe, CEO of Idaho Technology said, "The FilmArray RP is a powerful molecular diagnostic assay designed for comprehensive detection of common respiratory pathogens, and yet is still incredibly simple and easy to use," said Kirk Ririe, CEO of Idaho Technology.

Idaho Technology, Inc. licensed the rapid PCR technology from the University of Utah (Salt Lake City, UT, USA). The company has created many commercial instruments and reagents for use in applied and research fields. Several of these products, including the LightCycler Instrument, have been sublicensed to Roche Diagnostics (Basel, Switzerland). Laboratory personnel, researchers, law enforcement officers, and soldiers in the field use the company's devices to detect or study disease-causing organisms.

Related Links:

Idaho Technology
Children's Medical Center
UT Southwestern Medical Center
Detroit Medical Center
Medical University of South Carolina
US Food and Drug Administration
Roche Diagnostics



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.